Moreover, STn was found to be a marker of poor prognosis in bladder cancer and, in combination with PI3K/Akt/mTOR pathway evaluation, holds potential to improve disease stage stratification [20]. The gene discussed is EEF1A2; the disease is urinary bladder cancer.